Canada Backs London's Manikheir Inc. for Domestic PPE Production

Innovation, Science and Economic Development Canada

Latest subsidiary of internationally recognized company Medicom Group Inc. will establish manufacturing facility with capacity to produce up to one billion medical-grade nitrile gloves annually

The Government of Canada remains steadfast in safeguarding the health and safety of Canadians. During the pandemic, the historic demand for personal protective equipment (PPE) exceeded manufacturing capacity as health care workers and civilians alike did their part to safeguard their communities from the transmission of COVID-19. Outfitting health care workers with adequate infection control products is top of mind to ensure they can continue providing high-quality care to those in need.

Today, Peter Fragiskatos, Parliamentary Secretary to the Minister of Housing, Infrastructure and Communities, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced that the Government of Canada will contribute up to $42 million through the Strategic Innovation Fund (SIF) to support Manikheir Canada Inc.'s project to build a facility in London, Ontario, to develop and produce medical-grade nitrile gloves. The manufacturing facility will have an annual production capacity of up to one billion medical-grade nitrile gloves to be used across multiple commercial segments including dental, industrial, medical, lab/research and retail, allowing for domestic preparedness for future pandemics.

Manikheir will be the only medical-grade nitrile glove manufacturer in the country, supporting the government's commitment to keep Canadian health care workers protected. This project aligns with Canada's Biomanufacturing and Life Sciences Strategy, and with this contribution, Manikheir will create 135 jobs in London, Ontario.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.